APA (7th ed.) Citation

S, N., C, N., B, P., I, L., G, P., M, B., . . . E, M. (2014). Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma. Leukemia & lymphoma, 55(9), 2071. https://doi.org/10.3109/10428194.2013.866665

Chicago Style (17th ed.) Citation

S, Nobili, et al. "Identification of Pharmacogenomic Markers of Clinical Efficacy in a Dose-dense Therapy Regimen (R-CHOP14) in Diffuse Large B-cell Lymphoma." Leukemia & Lymphoma 55, no. 9 (2014): 2071. https://doi.org/10.3109/10428194.2013.866665.

MLA (9th ed.) Citation

S, Nobili, et al. "Identification of Pharmacogenomic Markers of Clinical Efficacy in a Dose-dense Therapy Regimen (R-CHOP14) in Diffuse Large B-cell Lymphoma." Leukemia & Lymphoma, vol. 55, no. 9, 2014, p. 2071, https://doi.org/10.3109/10428194.2013.866665.